
William Katkov, M.D.
Dr. William Katkov is a gastroenterologist who is currently affiliated with Cedars-Sinai Marina del Rey Hospital. He attended Keck School of Medicine – University of Southern California and graduated in 1983. The physician completed his residency and fellowship at the Massachusetts General Hospital. In 2010 and 2011, he received the Patients' Choice Award and the Compassionate Doctor Recognition and he is also the recipient of the Super Doc award. Dr. William Katkov is a Fellow of the American College of Physicians. Dr. William Katkov has over 30 years of professional experience. He is certified by the American Board of Internal Medicine.
Conditions Dr. William Katkov Treats at Cedars-Sinai Marina del Rey Hospital
Insurance Accepted
- Aetna Choice POS II
- Blue Cross / Blue Shield
- Cigna
- First Health PPO
- Great West PPO
- Aetna
- Blue Shield of California
- CareFirst BCBS
- Humana
- MultiPlan
Languages Spoken
- English
- Spanish
Education & Training

Medical Degree
Keck School of Medicine – University of Southern California

Internship(s)
N/A

Residency(ies)
Massachusetts General Hospital

Fellowship(s)
Massachusetts General Hospital
Memberships & Affiliations
Publications & Media
-
Sulindac and Indomethacin Suppress the Diuretic Action of Furosemide in Patients With Cirrhosis and Ascites: Evidence That Sulindac Affects Renal Prostaglandins.
George Daskalopoulos, Ian Kronborg, William Katkov, Mark Gonzalez, Giacomo Laffi, Robert D. Zipser
-
Endotracheal intubation in massive hemoptysis: advantages of the orotracheal route.
William N. Katkov, Mark J. Ault
-
Brief report: lymphoma of donor origin occurring in the porta hepatis of a transplanted liver.
Spiro, I. J., Yandell, D. W., Li, C., Saini, S., Ferry, J., Powelson, J., Katkov, W. N., Cosimi, A. B.
-
Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial.
Sanjeev Arora, William N. Katkov, Jeffery S. Cooley, James Alan Kemp, David E. Johnston, Robert H. Schapiro, Daniel K. Podolsky
-
Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group.
Karen L. Lindsay, Gary L. Davis, Eugene R. Schiff, Henry C. Bodenheimer, Luis A. Balart, Jules L. Dienstag, Robert P. Perrillo, Carlo H. Tamburro, John S. Goff, Gregory T. Everson, Marcelo Silva, William N. Katkov, Zachary D. Goodman, Johnson Y.N. Lau, Geert Maertens, Jagadish Gogate, Bharati Sanghvi, Janice K. Albrecht